Back to top
February 9, 2018
CURE-backed research finds biomarker to halt seizures post brain injury
Research, CURE News

As reported by Katie Pfaff, BioWorld MedTech:

Research may have pinpointed a biomarker for epilepsy after stroke, a condition with unpredictable onset and few treatment options. Funded by nonprofit Citizens United for Research in Epilepsy (CURE), the Italian-based research team has discovered a protein in animal model tied to development of seizures following brain injury.

Lead by Annamaria Vezzani, researchers at Milan's Mario Negri Institute for Pharmacological Research have identified the biomarker HMGB1, which was found to spike among studied animals before development of epilepsy. Research was conducted in a rat model and may point to possible inception of epilepsy after injury to the brain. HMGB1 is commonly associated with neuroinflammation in the brain after injury and may mean such inflammation can be treated with medication to hold off seizures or decrease their severity.

"With this research, Vezzani and her team have provided hope that a treatment for preventing acquired epilepsy before it occurs is on the horizon," said Kate Carr, CEO, CURE.

Learn More

 

Related News

August 9, 2018
Crowdsourced Algorithms Predict Epilepsy Seizures

Thanks to the crowdsourcing of more than 10,000 algorithms from around the world, epileptic seizure prediction is possible in a wider range of...

Read More
August 9, 2018
Environmental Enrichment Alleviates Cognitive and...

[Researchers state] these findings suggest that environmental enrichment effectively ameliorates cognitive and behavioral deficits in EL mice....

Read More
August 9, 2018
Compound from Spider Venom Reduces Seizure Susceptibility,...

A CURE Grantee and other researchers discovered that a compound isolated from spider venom called Hm1a helps reduce seizure susceptibility and...

Read More